Panagora Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Panagora Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-14,169	Closed	-$2.55M	–	2435
2017 Q3	$2.55M	Buy	+14,169	New	+$1.97M	0.01%	773
2016 Q4	–	Sell	-26,866	Closed	-$1.5M	–	2461
2016 Q3	$1.5M	Buy	+26,866	New	+$1.5M	0.01%	1037
2015 Q4	–	Sell	-353	Closed	-$20K	–	2429
2015 Q3	$20K	Buy	+353	New	+$22.2K	﹤0.01%	2141

Panagora Asset Management's KITE Position: Q4 2017 in Review

Panagora Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 14,169 shares — an estimated $2.55M sold.

Panagora Asset Management first reported a position in KITE in Q3 2015 and held it in 3 quarters. The position peaked at $2.55M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Panagora Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Panagora Asset Management sold 14,169 Kite Pharma, Inc. shares in Q4 2017, an estimated $2.55M.
Panagora Asset Management first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 3 quarters.
Panagora Asset Management's Kite Pharma, Inc. position peaked at $2.55M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Panagora Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.